About Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals is a company based in Milford (United States) founded in 2002.. Spring Bank Pharmaceuticals has raised $36.7 million across 10 funding rounds from investors including NIH, HHS and European Union. The company has 84 employees as of February 28, 2022. Spring Bank Pharmaceuticals operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Chimerix, HOOKIPA Pharma and Novavax, among others.
- Headquarter Milford, United States
- Employees 84 as on 28 Feb, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name F-Star Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$36.7 M (USD)
in 10 rounds
-
Latest Funding Round
-
Investors
NIH
& 3 more
-
Employee Count
84
as on Feb 28, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals has successfully raised a total of $36.7M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Last Round
-
First Round
First Round
(14 Jul 2009)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - Spring Bank Pharmaceuticals | Valuation |
investors |
|
| Nov, 2016 | Amount | Post-IPO - Spring Bank Pharmaceuticals | Valuation |
investors |
|
| Feb, 2015 | Amount | Series B - Spring Bank Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Invests in biotech firms developing life-saving drugs and technologies.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spring Bank Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Spring Bank Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spring Bank Pharmaceuticals Comparisons
Competitors of Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Chimerix, HOOKIPA Pharma and Novavax, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Spring Bank Pharmaceuticals
Frequently Asked Questions about Spring Bank Pharmaceuticals
When was Spring Bank Pharmaceuticals founded?
Spring Bank Pharmaceuticals was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Where is Spring Bank Pharmaceuticals located?
Spring Bank Pharmaceuticals is headquartered in Milford, United States.
Is Spring Bank Pharmaceuticals a funded company?
Spring Bank Pharmaceuticals is a funded company, having raised a total of $36.7M across 10 funding rounds to date. The company's 1st funding round was a Series B of $22M, raised on Jul 14, 2009.
How many employees does Spring Bank Pharmaceuticals have?
As of Feb 28, 2022, the latest employee count at Spring Bank Pharmaceuticals is 84.
What does Spring Bank Pharmaceuticals do?
Spring Bank Pharmaceuticals was founded in 2002 and is based in Milford, United States. Operations center on the pharmaceutical sector, where small molecule nucleic acid hybrid compounds are developed to target proteins and enzymes in disease states. SB 9200 is being advanced for viral diseases, including hepatitis B virus and respiratory syncytial virus, by activating immune response proteins in infected cells.
Who are the top competitors of Spring Bank Pharmaceuticals?
Spring Bank Pharmaceuticals's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
Who are Spring Bank Pharmaceuticals's investors?
Spring Bank Pharmaceuticals has 4 investors. Key investors include NIH, HHS, European Union, and Turmeric Acquisition Corp.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.